trifolium pratense Report issue

Allergen Experimental
AACT

Active Ingredient History

NOW
  • Now
Trifolium pratense, red clover, is a herbaceous species of flowering plant in the bean family Fabaceae, native to Europe, Western Asia, and northwest Africa, but planted and naturalized in many other regions.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

alk phleum pratense | alutard phleum pratense | depigoid phleum | phleum pratense allergen | phleum pratense allergen extract | phleum pretense allergen | poa pratensis allergen extract | p. pratense pollen extract | sublivac fix phleum prat. | trifolium pratense

Organizations (52)

Research & Development (52)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Allergy and Immunology (Phase 2)

Asthma (Phase 2/Phase 3)

Conjunctivitis (Phase 3)

Conjunctivitis, Allergic (Phase 2)

Drugs, Investigational (Phase 2)

Healthy Volunteers (Phase 3)

Hot Flashes (Phase 2)

Hypersensitivity (Phase 2/Phase 3)

Immune Tolerance (Phase 2)

Menopause (Phase 2)

Pain (Phase 2)

Rhinitis (Phase 2/Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 31
  • # of Trial Organizations: 52

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue